Frazier Healthcare Partners Launches Recida Therapeutics to Develop Novel Therapeutics for Serious Antibiotic-Resistant Infections

Life Science

DNAnexus Completes $68 Million Financing

Life Science

Bolt Bio Closes $54 Million Round Led by Hong Kong’s Pivotal/Nan Fung

Life Science

Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market

Cannabis, Life Science

Reaction Biology Corporation Purchases ProQinase GmbH

Life Science

Kaneka invests in a US-based medical device company

Life Science

Indivior Out-Licenses China Rights To Opioid Treatment in $122.5 Million Pact

Life Science

POT stock ticker generates frenzy as WHO softens stance on marijuana

Cannabis, Life Science

Senseonics Announces Extension of Distribution Agreement with Roche Diabetes Care

Life Science

Mobidiag Announces Completion of €10m Equity Investment from Autobio Diagnostics

Life Science

EdiGene Completes $10 Million Round for Gene Editing-based Discovery

Life Science

Novartis’ CAR-T Treatment Kymriah Snags Second Approval in the U.K.

Life Science

Hua Starts US Trial of Lead Type 2 Diabetes Treatment, a GKA Activator

Life Science

I-Mab Signs Collaboration MOU with Hong Kong’s Bio-Cancer Treatment

Life Science

Cannabis stocks look set to flourish thanks to Trump’s 2018 Farm Bill

Cannabis, Life Science